Last Friday, the FDA approved of HPV vaccination of older women – at the end of a week in which a blockbuster book came out that highlights serious issues with the HPV vaccine – including troubling safety signals that the FDA knows about.
Previously, the vaccine had been approved for use ages 9-26, although scant data exists on the efficacy and safety in 9-year olds. The FDA extended the approved use into an age group (27 to 45 years old women), some of whom will now almost certainly feel the effects of FDA’s latest flawed approval by experiencing autoimmunity, paralysis and death.
What the FDA Knows We Now Know, Too
From the information submitted from Merck to the US FDA, it is apparent that the vaccine used in Protocol 018, the only study of the safety of the vaccine market group (9-15 year-olds) used only one-half the standard AAHS dose…
View original post 502 more words